Fluorescence Anisotropy Assay with Guanine Nucleotides Provides Access to Functional Analysis of Gαi1 Proteins.


Journal

Analytical chemistry
ISSN: 1520-6882
Titre abrégé: Anal Chem
Pays: United States
ID NLM: 0370536

Informations de publication

Date de publication:
18 10 2022
Historique:
pubmed: 8 10 2022
medline: 20 10 2022
entrez: 7 10 2022
Statut: ppublish

Résumé

Gα proteins as part of heterotrimeric G proteins are molecular switches essential for G protein-coupled receptor- mediated intracellular signaling. The role of the Gα subunits has been examined for decades with various guanine nucleotides to elucidate the activation mechanism and Gα protein-dependent signal transduction. Several approaches describe fluorescent ligands mimicking the GTP function, yet lack the efficient estimation of the proteins' GTP binding activity and the fraction of active protein. Herein, we report the development of a reliable fluorescence anisotropy-based method to determine the affinity of ligands at the GTP-binding site and to quantify the fraction of active Gαi1 protein. An advanced bacterial expression protocol was applied to produce active human Gαi1 protein, whose GTP binding capability was determined with novel fluorescently labeled guanine nucleotides acting as high-affinity Gαi1 binders compared to the commonly used BODIPY FL GTPγS. This study thus contributes a new method for future investigations of the characterization of Gαi and other Gα protein subunits, exploring their corresponding signal transduction systems and potential for biomedical applications.

Identifiants

pubmed: 36206384
doi: 10.1021/acs.analchem.2c03176
doi:

Substances chimiques

Guanine Nucleotides 0
Ligands 0
Protein Subunits 0
Receptors, G-Protein-Coupled 0
Guanosine Triphosphate 86-01-1
Heterotrimeric GTP-Binding Proteins EC 3.6.5.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14410-14418

Auteurs

Anna Pepanian (A)

Pharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, 53121 Bonn, Germany.

Paul Sommerfeld (P)

Institutes I & II of Pharmacology, Center of Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.

Renata Kasprzyk (R)

Centre of New Technologies, University of Warsaw, 02-097 Warsaw, Poland.

Toni Kühl (T)

Pharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, 53121 Bonn, Germany.

F Ayberk Binbay (FA)

Pharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, 53121 Bonn, Germany.

Christoph Hauser (C)

Institutes I & II of Pharmacology, Center of Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.

Reik Löser (R)

Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.

Robert Wodtke (R)

Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.

Marcelina Bednarczyk (M)

Centre of New Technologies, University of Warsaw, 02-097 Warsaw, Poland.
Division of Biophysics, Faculty of Physics, University of Warsaw, 02-093 Warsaw, Poland.

Mikolaj Chrominski (M)

Centre of New Technologies, University of Warsaw, 02-097 Warsaw, Poland.

Joanna Kowalska (J)

Division of Biophysics, Faculty of Physics, University of Warsaw, 02-093 Warsaw, Poland.

Jacek Jemielity (J)

Centre of New Technologies, University of Warsaw, 02-097 Warsaw, Poland.

Diana Imhof (D)

Pharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, 53121 Bonn, Germany.

Markus Pietsch (M)

Institutes I & II of Pharmacology, Center of Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH